Health is our business

Tigecycline Webinar on MDR Bacteria Management

Webinar

By Website Admin 7 Mar/ 0 Comment/ 102 Hits/

The anti-infective team of Pfizer company, in collaboration with Shiraz and Isfahan Universities of Medical Sciences, held a scientific program on the administration of Tygecycline in drug-resistant infections on October 1, 2021.




The anti-infective team of Pfizer company, in collaboration with Shiraz and Isfahan Universities of Medical Sciences, held a scientific program on the administration of Tygecycline in drug-resistant infections on October 1, 2021. This program began with a speech by Dr. Mohsen Moghadami, a full professor at Shiraz University of Medical Sciences, regarding medical information on medicine. Then, Dr. Farid Zand, intensive care specialist of Namazi Hospital, presented his case and described his treatment experience with Tygecycline. The program continued with a lecture by Dr. Elahe Nasri on the effectiveness of Tygecycline in controlling sepsis in patients with leukemia. The program ended with a great ovation from the audience and their questions were answered, and at the end, the slides of the program were given to the professors.

Share
Submit a comment